XENE
Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. (XENE) has 10 SEC Form 4 filings (12 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jun 8, 2026.
Insiders have net sold $133K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Andrea DiFabio
- Employees:316
- HQ:Burnaby, BC, CA
- IPO:2014-11-05
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$133K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$6.1B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
PATOU GARYFirst filing | Director | Sale | 1,322 | $70K | Jun 8 | SEC ↗ |
Cannon GillianFirst filing | Director | Sale | 1,190 | $63K | Jun 8 | SEC ↗ |
Related companies
Xenon Pharmaceuticals Inc. is in the Healthcare sector.